- Home
- MRT vs KOD Comparison
MRT vs KOD Comparison
Compare MRT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRT
- KOD
- Stock Information
- Founded
- MRT 2018
- KOD 2009
- Country
- MRT Turkey
- KOD United States
- Employees
- MRT N/A
- KOD N/A
- Industry
- MRT Rental/Leasing Companies
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRT Consumer Discretionary
- KOD Health Care
- Exchange
- MRT Nasdaq
- KOD Nasdaq
- Market Cap
- MRT 228.0M
- KOD 198.4M
- IPO Year
- MRT N/A
- KOD 2018
- Fundamental
- Price
- MRT $2.99
- KOD $4.38
- Analyst Decision
- MRT Strong Buy
- KOD Hold
- Analyst Count
- MRT 2
- KOD 3
- Target Price
- MRT $6.00
- KOD $9.00
- AVG Volume (30 Days)
- MRT 88.9K
- KOD 301.5K
- Earning Date
- MRT 01-01-0001
- KOD 08-13-2025
- Dividend Yield
- MRT N/A
- KOD N/A
- EPS Growth
- MRT N/A
- KOD N/A
- EPS
- MRT N/A
- KOD N/A
- Revenue
- MRT $18,659,655.00
- KOD N/A
- Revenue This Year
- MRT $83.29
- KOD N/A
- Revenue Next Year
- MRT $106.66
- KOD N/A
- P/E Ratio
- MRT N/A
- KOD N/A
- Revenue Growth
- MRT N/A
- KOD N/A
- 52 Week Low
- MRT $1.32
- KOD $1.92
- 52 Week High
- MRT $3.89
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- MRT 51.40
- KOD 65.72
- Support Level
- MRT $2.86
- KOD $3.70
- Resistance Level
- MRT $3.04
- KOD $4.01
- Average True Range (ATR)
- MRT 0.15
- KOD 0.25
- MACD
- MRT 0.03
- KOD 0.08
- Stochastic Oscillator
- MRT 63.33
- KOD 97.70
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.